Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Kantor

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Health Affairs (Project Hope)|May 8, 2018
Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic TestingSusanne B Haga, Ariel Kantor
Journal of Personalized Medicine|January 20, 2021
The Potential Benefit of Expedited Development and Approval Programs in Precision MedicineAriel Kantor, Susanne B Haga
International Journal of Molecular Sciences|September 3, 2020
CRISPR-Cas9 DNA Base-Editing and Prime-EditingAriel Kantor, Michelle E McClements, Robert E MacLaren
Pharmaceutics|September 23, 2022
Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and LimitationsAhmed Salman, Ariel Kantor, Michelle E McClements, et al.
Expert Opinion on Orphan Drugs|May 27, 2021
Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?Ruofan Connie Han, Lewis E Fry, Ariel Kantor, et al.
The Journal of Knee Surgery|September 7, 2018
What Is the Price and Claimed Efficacy of Platelet-Rich Plasma Injections for the Treatment of Knee Osteoarthritis in the United States?Nicolas S Piuzzi, Mitchell Ng, Ariel Kantor, et al.
Human Gene Therapy|September 30, 2020
Genome-Editing Strategies for Treating Human Retinal DegenerationsJoel Quinn, Ayesha Musa, Ariel Kantor, et al.
Progress in Molecular Biology and Translational Science|June 27, 2021
CRISPR genome engineering for retinal diseasesAriel Kantor, Michelle E McClements, Caroline F Peddle, et al.
Nature Biotechnology|June 2, 2025
Dual SORT LNPs for multi-organ base editingMinjeong Kim, Eunice S Song, Joseph C Chen, et al.
Nature Methods|August 3, 2021
Transgenic mice for in vivo epigenome editing with CRISPR-based systemsMatthew P Gemberling, Keith Siklenka, Erica Rodriguez, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Health Affairs (Project Hope)|May 8, 2018
Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic TestingSusanne B Haga, Ariel Kantor
Journal of Personalized Medicine|January 20, 2021
The Potential Benefit of Expedited Development and Approval Programs in Precision MedicineAriel Kantor, Susanne B Haga
International Journal of Molecular Sciences|September 3, 2020
CRISPR-Cas9 DNA Base-Editing and Prime-EditingAriel Kantor, Michelle E McClements, Robert E MacLaren
Pharmaceutics|September 23, 2022
Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and LimitationsAhmed Salman, Ariel Kantor, Michelle E McClements, et al.
Expert Opinion on Orphan Drugs|May 27, 2021
Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?Ruofan Connie Han, Lewis E Fry, Ariel Kantor, et al.
The Journal of Knee Surgery|September 7, 2018
What Is the Price and Claimed Efficacy of Platelet-Rich Plasma Injections for the Treatment of Knee Osteoarthritis in the United States?Nicolas S Piuzzi, Mitchell Ng, Ariel Kantor, et al.
Human Gene Therapy|September 30, 2020
Genome-Editing Strategies for Treating Human Retinal DegenerationsJoel Quinn, Ayesha Musa, Ariel Kantor, et al.
Progress in Molecular Biology and Translational Science|June 27, 2021
CRISPR genome engineering for retinal diseasesAriel Kantor, Michelle E McClements, Caroline F Peddle, et al.
Nature Biotechnology|June 2, 2025
Dual SORT LNPs for multi-organ base editingMinjeong Kim, Eunice S Song, Joseph C Chen, et al.
Nature Methods|August 3, 2021
Transgenic mice for in vivo epigenome editing with CRISPR-based systemsMatthew P Gemberling, Keith Siklenka, Erica Rodriguez, et al.
Pageof 1